243 related articles for article (PubMed ID: 18952105)
1. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
Handel A; Longini IM; Antia R
J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
[TBL] [Abstract][Full Text] [Related]
2. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
3. Antiviral resistance and the control of pandemic influenza.
Lipsitch M; Cohen T; Murray M; Levin BR
PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
[TBL] [Abstract][Full Text] [Related]
4. Modeling the effects of drug resistant influenza virus in a pandemic.
Brockmann SO; Schwehm M; Duerr HP; Witschi M; Koch D; Vidondo B; Eichner M
Virol J; 2008 Oct; 5():133. PubMed ID: 18973656
[TBL] [Abstract][Full Text] [Related]
5. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on antiviral use during pandemic influenza.
Hayden FG
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387
[TBL] [Abstract][Full Text] [Related]
7. Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.
Arino J; Bowman CS; Moghadas SM
BMC Infect Dis; 2009 Jan; 9():8. PubMed ID: 19161634
[TBL] [Abstract][Full Text] [Related]
8. Emergence of drug resistance: implications for antiviral control of pandemic influenza.
Alexander ME; Bowman CS; Feng Z; Gardam M; Moghadas SM; Röst G; Wu J; Yan P
Proc Biol Sci; 2007 Jul; 274(1619):1675-84. PubMed ID: 17507331
[TBL] [Abstract][Full Text] [Related]
9. Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
Dafilis MP; Moss R; McVernon J; McCaw J
Epidemics; 2012 Dec; 4(4):219-26. PubMed ID: 23351374
[TBL] [Abstract][Full Text] [Related]
10. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
11. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
[TBL] [Abstract][Full Text] [Related]
12. Use of neuraminidase inhibitors to combat pandemic influenza.
Democratis J; Pareek M; Stephenson I
J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
[TBL] [Abstract][Full Text] [Related]
13. [Resistance in influenza viruses].
Hungnes O; Dudman SG
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
[TBL] [Abstract][Full Text] [Related]
14. [Antiviral treatment of influenza in humans].
Nüesch R
Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
[TBL] [Abstract][Full Text] [Related]
15. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
16. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
17. Epidemic patch models applied to pandemic influenza: contact matrix, stochasticity, robustness of predictions.
Lunelli A; Pugliese A; Rizzo C
Math Biosci; 2009 Jul; 220(1):24-33. PubMed ID: 19371752
[TBL] [Abstract][Full Text] [Related]
18. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
19. Pandemic influenza: its origin and control.
Laver G; Garman E
Microbes Infect; 2002 Nov; 4(13):1309-16. PubMed ID: 12443895
[TBL] [Abstract][Full Text] [Related]
20. Antiviral prophylaxis during pandemic influenza may increase drug resistance.
Eichner M; Schwehm M; Duerr HP; Witschi M; Koch D; Brockmann SO; Vidondo B
BMC Infect Dis; 2009 Jan; 9():4. PubMed ID: 19154598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
